DENISE PACK: Open Payments
NPI 1124732185 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 9 payments from 8 companies in 2025. Trend: 2023 $122 · 2024 $1,160 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $167 |
| Corcept Therapeutics | 1 | $127 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $119 |
| SANOFI-AVENTIS U.S. LLC | 1 | $119 |
Products named: Korlym, REXULTI, GATTEX, MOUNJARO, TZIELD, Wegovy.
Industry payments across TX — which companies pay providers there.
